463 related articles for article (PubMed ID: 22534511)
1. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
Armstrong LTD; Magnusson MR; Guppy MPB
J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
4. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
5. Disseminated basal cell carcinoma.
Tuncel A; Adanali G; Senen D; Erdogan B
Plast Reconstr Surg; 2003 Feb; 111(2):949-51. PubMed ID: 12560736
[No Abstract] [Full Text] [Related]
6. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
7. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
Angulo J; Serra-Guillén C; Traves V; Botella-Estrada R; Sanmartín O; Llombart B; Requena C; Guillén C; Nagore E
Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
[TBL] [Abstract][Full Text] [Related]
8. An assessment of incomplete facial Basal cell carcinoma excision.
Shah SA; Obaidullah ; Fahimullah
J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
[TBL] [Abstract][Full Text] [Related]
9. Effect of positive surgical margins after initial surgical resection for basal cell carcinoma.
Fernandes S; Macias VC; Cardoso J
Dermatol Surg; 2013 Jan; 39(1 Pt 1):139-40. PubMed ID: 22928594
[No Abstract] [Full Text] [Related]
10. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
11. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
12. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
13. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
[TBL] [Abstract][Full Text] [Related]
14. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
[TBL] [Abstract][Full Text] [Related]
15. [Two-stage excision of extensive cutaneous carcinoma of the face. A retrospective study of 80 patients].
Arfi C; Bureau B; Beauvillain C; Nguyen JM; Stalder JF; Litoux P
Ann Dermatol Venereol; 1995; 122(11-12):764-8. PubMed ID: 8729820
[TBL] [Abstract][Full Text] [Related]
16. Cryosurgery and curettage-cryosurgery for basal cell carcinomas of the mid-face.
Samain A; Boullié MC; Duval-Modeste AB; Joly P
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1291-6. PubMed ID: 25354233
[TBL] [Abstract][Full Text] [Related]
17. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
[TBL] [Abstract][Full Text] [Related]
18. Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma.
Mosterd K; Thissen MR; van Marion AM; Nelemans PJ; Lohman BG; Steijlen PM; Kelleners-Smeets NW
J Am Acad Dermatol; 2011 Feb; 64(2):323-7. PubMed ID: 21238826
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre.
Bourlidou E; Vahtsevanos K; Kyrgidis A; Tilaveridis I; Patsatsi A; Andreadis D; Cheva A; Patrikidou A; Kitikidou K; Boboridis K
Eur J Dermatol; 2019 Oct; 29(5):490-499. PubMed ID: 31789273
[TBL] [Abstract][Full Text] [Related]
20. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up.
van Loo E; Mosterd K; Krekels GA; Roozeboom MH; Ostertag JU; Dirksen CD; Steijlen PM; Neumann HA; Nelemans PJ; Kelleners-Smeets NW
Eur J Cancer; 2014 Nov; 50(17):3011-20. PubMed ID: 25262378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
